Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Reversal of General Anesthesia
NCT02051452Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate in Post-operative cognitive dysfunction (POCD), sponsored by Massachusetts General Hospital. Started Nov 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT02051452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02051452.